Patents

 

  1. U.S. Patent 9,328,324, System, method and devices for tissue-based diagnosis 
  2. U.S. Patent 9,308,181 Topical formulations, systems and methods 
  3. U.S. Patent 8,945,482System, method and device for tissue-based diagnosis
  4. U.S. Patent 8,870,810, Method and apparatus for enhancement of transdermal transport
  5. U.S. Patent 8,791,062 Skin permeating and cell entering (SPACE) peptides and methods of use thereof
  6. U.S. Patent 8,642,664 Composition for solubilizing tissue and cells comprising N-tetradecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate and polyoxyethylene (10) cetyl ether
  7. U.S. Patent 8,609,041, Apparatus for Solubilizing Tissue
  8. U.S. Patent 8,518,871, Skin Permeating and Cell Entering (SPACE) Peptides and Methods of Use Thereof
  9. U.S. Patent 8,513,304 Topical Formulations
  10. U.S. Patent 8,389,582 Composition for solubilizing tissue comprising 3-(decyl dimethyl ammonio) propane sulfonate and tetraethylene glycol dodecyl ether
  11. U.S. Patent 8,343,962, Topical Formulation
  12. U.S. Patent 8,287, 483, Method and apparatus for enhancement of transdermal transport
  13. U.S. Patent 8,277, 762, Apparatus and methods for evaluating the barrier properties of membrane
  14. U.S. patent 8,021,323, Soft tissue augmentation by needle-free injection.
  15. U.S. patent 7,795,309 Topical formulation including diclofenac, or a pharmaceutically acceptable salt thereof.
  16. U.S. patent 7,648,739 Switchable surfaces.
  17. U.S. patent 7,020,355, Switchable surfaces.
  18. U.S. patent 6,887,239, Preparation for transmission and reception of electrical signals.
  19. U.S. patent 6,620,123, Method and apparatus for producing homogenous cavitation to enhance transdermal transport
  20. U.S. patent 6,589,173, Ultrasound system for disease detection and patient treatment
  21. U.S. patent 6,491,657, Ultrasound enhancement of transdermal transport
  22. U.S. patent 6,234,990, Ultrasound enhancement of transdermal transport
  23. U.S. patent 6,190,315, Sonophoretic enhanced transdermal transport
  24. U.S. patent 6,041,253, Effect of electric field and ultrasound for transdermal drug delivery
  25. U.S. patent 6,018,678, Transdermal protein delivery or measurement using low-frequency sonophoresis
  26. U.S. patent 6,002,961, Transdermal protein delivery using low-frequency sonophoresis
  27. U.S. patent 5,947,921, Chemical and physical enhancers and ultrasound for transdermal drug delivery
  28. U.S. patent 5,814,599, Transdermal delivery of encapsulated drugs
  29. U.S. Patent application 20160235392, System, method and devices for tissue-based diagnosis 
  30. U.S. Patent application 20160101056, Mucoadhesive devices for delivery of active agents 
  31. U.S. Patent application 20160030726, Methods of delivering nanoshells into sebaceous glands
  32. U.S. Patent application 20160015890, SYSTEM AND METHOD OF VARIABLE DOSE GLUCAGON DELIVERY
  33. U.S. Patent application 20160000881, Oral Drug Devices and Drug Formulations 
  34. U.S. Patent application 20150297723, TOPICAL FORMULATIONS FOR TREATING SKIN CONDITIONS
  35. U.S. Patent application 20150238435, Oral Drug Devices and Drug Formulations
  36. U.S. Patent application 20150174076, MUCOADHESIVE DEVICES FOR DELIVERY OF ACTIVE AGENTS
  37. U.S. Patent application 20150025221, Skin Permeating and Cell Entering (SPACE) Peptides and Methods of Use Thereof
  38. U.S. Patent application 20140227174, Skin Permeating and Cell Entering (SPACE) Peptides and Methods of Use Therefor
  39. U.S. Patent application 20140161871, Skin Permeating and Cell Entering (SPACE) Peptides and Methods of Use Thereof
  40. U.S. Patent application 20140107560, compositions for solubilizing cells and/or tissue
  41. U.S. Patent application 20130337031, Topical Formulations, Systems and Methods
  42. U.S. Patent application 20130274352, Oral Drug Devices and Drug Formulations
  43. U.S. Patent application 2013115169, Red Blood Cell-mimetic particles and methods for making use thereof
  44. U.S. Patent application 20130079404, Topical Formulation
  45. U.S. Patent application 20130035566, Method and Apparatus for Enhancement of Transdermal Transport
  46. U.S. patent application 20120253238, COMPOSITIONS FOR SOLUBILIZING CELLS AND/OR TISSUE
  47. U.S. patent application 20120128756, Skin Permeating And Cell Entering (SPACE) Peptides and Methods of Use Thereof
  48. U.S. Patent application 20120045504, ORAL DRUG DEVICES AND DRUG FORMULATIONS
  49. U.S. Patent application 20120004592, COMPOSITIONS FOR SOLUBILIZING TISSUE
  50. U.S. Patent application 20110295149, APPARATUS FOR SOLUBILIZING TISSUE
  51. U.S. Patent application 20110212485, SYSTEM, METHOD AND DEVICE FOR TISSUE-BASED DIAGNOSIS
  52. U.S. Patent application 20110028460, TOPICAL FORMULATION
  53. U.S. Patent application 20100261176, Methods of Tissue-Based Diagnosis
  54. U.S. Patent application 20100217403, SWELLABLE HYALURONIC ACID PARTICLES
  55. U.S. Patent application 20100029769, TOPICAL FORMULATION
  56. U.S. Patent application 20090105260, Molecules to Enhance Percutaneous Delivery and Methods for Discovery Therefor
  57. U.S. Patent application 20090030367, SOFT TISSUE AUGMENTATION BY NEEDLE-FREE INJECTION
  58. U.S. Patent application 20090022808, Coated Hyaluronic Acid Particles
  59. U.S. Patent application 20080221212, TOPICAL FORMULATION
  60. U.S. Patent application 20080112886, ENGINEERING SHAPE OF POLYMERIC MICRO- AND NANOPARTICLES
  61. U.S. Patent application 20070269379, Penetration Enhancer Combinations for Transdermal Delivery
  62. U.S. Patent application 20070183936, Apparatus and methods for evaluating the barrier properties of a membrane
  63. U.S. Patent application 20060263033, Switchable surfaces
  64. U.S. Patent application 20060088579, Transdermal drug delivery systems
  65. U.S. Patent application 20060015058, Agents and methods for enhancement of transdermal transport
  66. U.S. Patent application 20050181029, Distributed drug dispensing matrix as a transdermal patch
  67. U.S. Patent application 20050049474, Preparation for transmission and reception of electrical signals
  68. U.S. Patent application 20040236268, Method and apparatus for enhancement of transdermal transport
  69. U.S. Patent application 20040210184, Effect of electric field and ultrasound for transdermal drug delivery
  70. U.S. Patent application 20040171980, Method and apparatus for enhancement of transdermal transport
  71. U.S. Patent application 20040087879, Method and apparatus for producing homogenous cavitation to enhance transdermal transport
  72. U.S. Patent application 20040039418, Preparation for transmission and reception of electrical signals
  73. U.S. Patent application 20040023841, Combinatorial method for rapid screening of drug delivery formulations
  74. U.S. Patent application 20030142901, Switchable surfaces
  75. U.S. Patent application 20030017195, Method for oral drug delivery
  76. U.S. Patent application 20020045850, Ultrasound enhancement of transdermal transport
  77. U.S. Patent application 20010056255, Effect of electric field and ultrasound for transdermal drug delivery
  78. PCT (WO/2015/117158) SYNTHETIC PLATELETS
  79. PCT (WO/2015/066647) IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY
  80. PCT (WO/2015/026552) MUCOADHESIVE DEVICES FOR DELIVERY OF ACTIVE AGENTS
  81. PCT (WO/2014/160404) IMPROVED ORAL DRUG DEVICES AND DRUG FORMULATIONS
  82. PCT (WO/2014/145784) METHODS OF DELIVERING NANOSHELLS INTO SEBACEOUS GLANDS
  83. PCT (WO/2014/123543) SKIN PERMEATING AND CELL ENTERING (SPACE) PEPTIDES AND METHODS OF USE
  84. PCT (WO/2013/188819) Mucoadhesive devices for delivery of active agents
  85. PCT (WO/2013/172832) Compositions for Solubilizing Cells and/or Tissue
  86. PCT (WO/2012/064429) SKIN PERMEATING AND CELL ENTERING (SPACE) PEPTIDES AND METHODS OF USE THEREOF
  87. PCT (WO/2011/069082) RED BLOOD CELL-MIMETIC PARTICLES AND METHODS FOR MAKING AND USE THEREOF
  88. PCT (WO 2010/120892) Improved oral drug devices and drug formulations
  89. PCT (WO 2010/093861) System, method and device for tissue-based diagnostics
  90. PCT (WO 2009/048681) Methods of Tissue-based diagnostics
  91. PCT (WO 2008/147817) Coated Hyaluronic Acid Particles
  92. PCT (WO 2008/031035) Engineering shape of polymeric micro- and nanoparticles
  93. PCT (WO 2007/102090) Topical formulation
  94. PCT (WO 2006/091877) Agents and methods for enhancement of transdermal transport.
  95. PCT (WO 2006/091297) Molecules to enhance percutaneous delivery and methods for discovery therefore
  96. PCT (WO 2005/012549) Apparatus and methods for evaluating the barrier properties of a membrane
  97. PCT (WO 2005/009510) Penetration enhancer combinations for transdermal delivery
  98. PCT (WO 2004/032970) Carriers attached to blood cells
  99. PCT (WO 2003/090366) Preparation for transmission and reception of electrical signals
  100. PCT (WO 2003/066130) Transdermal drug delivery systems
  101. PCT (WO 2003/055590) Switchable surfaces
  102. PCT (2003/007913) Method for oral drug delivery
  103. PCT (2002/016941) A combinatorial method for rapid screening of drug delivery formulations
  104. PCT (WO 2001/076553) Method and device for enhanced transdermal drug delivery
  105. PCT (WO 2000/035357) Method and apparatus for enhancement of transdermal transport
  106. PCT (WO 2000/035351) Method and apparatus for producing homogeneous cavitation to enhance transdermal transport
  107. PCT (WO 034857) Sonophoretic enhanced transdermal transport
  108. PCT (WO 1998/000194) Ultrasound enhancement of transdermal transport
  109. PCT (WO 1997/004832) Enhanced transdermal transport using ultrasound

Unpublished patent applications not listed